hc toxin has been researched along with Bile Duct Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Duan, X; He, J; He, K; Huang, R; Xia, Z; Xiang, G; Xiao, J; Zhang, J; Zhou, W | 1 |
1 other study(ies) available for hc toxin and Bile Duct Neoplasms
| Article | Year |
|---|---|
Histone deacetylase inhibitor screening identifies HC toxin as the most effective in intrahepatic cholangiocarcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Bile Duct Neoplasms; Cell Line, Tumor; Cell Shape; Cell Survival; Cholangiocarcinoma; Deoxycytidine; Drug Screening Assays, Antitumor; Gemcitabine; Histone Deacetylase Inhibitors; Humans; Inhibitory Concentration 50; Peptides, Cyclic | 2016 |